Long intergenic
non-coding RNA for
kinase activation (LINK-A) has been characterized as an oncogenic long non-coding (lnc)
RNA in
triple-negative breast cancer and ovarian
carcinoma, but its involvement in other
malignancies remains elusive. In the present study, it was determined that the plasma levels of LINK-A
lncRNA and Rho-associated
protein kinase 1 (ROCK1) were significantly increased in patients with pancreatic
adenocarcinoma compared with those in healthy controls. The plasma levels of LINK-A
lncRNA were positively correlated with the plasma levels of ROCK1 in pancreatic
adenocarcinoma patients, but not in healthy controls. Silencing of LINK-A led to inhibition of pancreatic
adenocarcinoma cell proliferation, migration and invasion. Simultaneous overexpression of ROCK1 attenuated the inhibitory effect of LINK-A silencing on
cancer cell proliferation, migration and invasion. Overexpression of LINK-A
lncRNA led to upregulation of ROCK1 expression, while overexpression of ROCK1 had no significant effect on LINK-A
lncRNA expression. It may therefore be concluded that LINK-A
lncRNA may have a role in pancreatic
adenocarcinoma, at least in part, by promoting ROCK1 expression.